Market revenue in 2023 | USD 732.3 million |
Market revenue in 2030 | USD 1,217.4 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Docosahexaenoic acid (dha) |
Fastest growing segment | DPA |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-linolenic acid (ALA), DPA |
Key market players worldwide | Orkla ASA, Basf SE, Omega Laboratories, Lonza Group Ltd, Croda International PLC, Austevoll Seafood ASA, Koninklijke DSM NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to omega 3 market will help companies and investors design strategic landscapes.
Docosahexaenoic acid (dha) was the largest segment with a revenue share of 55.05% in 2023. Horizon Databook has segmented the U.S. omega 3 market based on docosahexaenoic acid (dha), eicosapentaenoic acid (epa), alpha-linolenic acid (ala), dpa covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for omega 3 fatty acids in the U.S. is projected to grow significantly over the next few years owing to rising consumer awareness in the country regarding the health benefits offered by these acids. Moreover, growing consumer preference for a healthy diet that is rich in omega 3 nutrients is further projected to fuel the growth of omega 3 market in the U.S. over the forecast period.
Numerous omega 3 manufacturers present in the U.S., including BioProcess Algae, Martek Biosciences Corporation, and Omega Protein Corporation focus on research and development activities for launching pharmaceutical-grade omega 3 in the market.
This factor, along with increasing consumption of enhanced medicines to treat and prevent chronic diseases, is anticipated to spur the overall consumption of omega 3 in the U.S. in the coming years. Fish oil lowers blood pressure and triglyceride levels in consumers that help improve the conditions of hypertension and high cholesterol in adults.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. omega 3 market , including forecasts for subscribers. This country databook contains high-level insights into U.S. omega 3 market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account